Calreticulin promotes immunity and type I interferon-dependent survival in mice with acute myeloid leukemia.
Calreticulin promotes immunity and type I interferon-dependent survival in mice with acute myeloid leukemia. Oncoimmunology. 2017; 6(4):e1278332.